241 related articles for article (PubMed ID: 35022570)
21. Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer.
Zou H; Luo J; Guo Y; Tong T; Liu Y; Chen Y; Xiao Y; Ye L; Zhu C; Deng L; Wang B; Pan Y; Li P
Cell Mol Life Sci; 2023 Jan; 80(2):41. PubMed ID: 36633714
[TBL] [Abstract][Full Text] [Related]
22. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
[TBL] [Abstract][Full Text] [Related]
23. Curcumin promotes KLF5 proteasome degradation through downregulating YAP/TAZ in bladder cancer cells.
Gao Y; Shi Q; Xu S; Du C; Liang L; Wu K; Wang K; Wang X; Chang LS; He D; Guo P
Int J Mol Sci; 2014 Aug; 15(9):15173-87. PubMed ID: 25170806
[TBL] [Abstract][Full Text] [Related]
24. Krüppel-like factor 5 promotes lung tumorigenesis through upregulation of Sox4.
Li Q; Dong Z; Zhou F; Cai X; Gao Y; Wang LW
Cell Physiol Biochem; 2014; 33(1):1-10. PubMed ID: 24401325
[TBL] [Abstract][Full Text] [Related]
25. YB-1 transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal-like breast cancer.
Davies AH; Reipas KM; Pambid MR; Berns R; Stratford AL; Fotovati A; Firmino N; Astanehe A; Hu K; Maxwell C; Mills GB; Dunn SE
Stem Cells; 2014 Jun; 32(6):1437-50. PubMed ID: 24648416
[TBL] [Abstract][Full Text] [Related]
26. USP3 promotes breast cancer cell proliferation by deubiquitinating KLF5.
Wu Y; Qin J; Li F; Yang C; Li Z; Zhou Z; Zhang H; Li Y; Wang X; Liu R; Tao Q; Chen W; Chen C
J Biol Chem; 2019 Nov; 294(47):17837-17847. PubMed ID: 31624151
[TBL] [Abstract][Full Text] [Related]
27. The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation.
Zhao D; Zheng HQ; Zhou Z; Chen C
Cancer Res; 2010 Jun; 70(11):4728-38. PubMed ID: 20484041
[TBL] [Abstract][Full Text] [Related]
28. Krüppel-like factor 5 in human breast carcinoma: a potent prognostic factor induced by androgens.
Takagi K; Miki Y; Onodera Y; Nakamura Y; Ishida T; Watanabe M; Inoue S; Sasano H; Suzuki T
Endocr Relat Cancer; 2012 Dec; 19(6):741-50. PubMed ID: 22936544
[TBL] [Abstract][Full Text] [Related]
29. Ataxin-3 like (ATXN3L), a member of the Josephin family of deubiquitinating enzymes, promotes breast cancer proliferation by deubiquitinating Krüppel-like factor 5 (KLF5).
Ge F; Chen W; Qin J; Zhou Z; Liu R; Liu L; Tan J; Zou T; Li H; Ren G; Chen C
Oncotarget; 2015 Aug; 6(25):21369-78. PubMed ID: 26079537
[TBL] [Abstract][Full Text] [Related]
30. Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells.
Sutherland BW; Kucab J; Wu J; Lee C; Cheang MC; Yorida E; Turbin D; Dedhar S; Nelson C; Pollak M; Leighton Grimes H; Miller K; Badve S; Huntsman D; Blake-Gilks C; Chen M; Pallen CJ; Dunn SE
Oncogene; 2005 Jun; 24(26):4281-92. PubMed ID: 15806160
[TBL] [Abstract][Full Text] [Related]
31. Links between the oncoprotein YB-1 and small non-coding RNAs in breast cancer.
Blenkiron C; Hurley DG; Fitzgerald S; Print CG; Lasham A
PLoS One; 2013; 8(11):e80171. PubMed ID: 24260353
[TBL] [Abstract][Full Text] [Related]
32. Fisetin targets YB-1/RSK axis independent of its effect on ERK signaling: insights from in vitro and in vivo melanoma models.
Sechi M; Lall RK; Afolabi SO; Singh A; Joshi DC; Chiu SY; Mukhtar H; Syed DN
Sci Rep; 2018 Oct; 8(1):15726. PubMed ID: 30356079
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of Kruppel-like factor 5 in esophageal epithelia in vivo leads to increased proliferation in basal but not suprabasal cells.
Goldstein BG; Chao HH; Yang Y; Yermolina YA; Tobias JW; Katz JP
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1784-92. PubMed ID: 17395897
[TBL] [Abstract][Full Text] [Related]
34. KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8
Wu Q; Liu Z; Gao Z; Luo Y; Li F; Yang C; Wang T; Meng X; Chen H; Li J; Kong Y; Dong C; Sun S; Chen C
Theranostics; 2023; 13(4):1381-1400. PubMed ID: 36923542
[No Abstract] [Full Text] [Related]
35. The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1.
Astanehe A; Finkbeiner MR; Hojabrpour P; To K; Fotovati A; Shadeo A; Stratford AL; Lam WL; Berquin IM; Duronio V; Dunn SE
Oncogene; 2009 Jun; 28(25):2406-18. PubMed ID: 19430491
[TBL] [Abstract][Full Text] [Related]
36. Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability.
Law JH; Li Y; To K; Wang M; Astanehe A; Lambie K; Dhillon J; Jones SJ; Gleave ME; Eaves CJ; Dunn SE
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844753
[TBL] [Abstract][Full Text] [Related]
37. Protein inhibitor of activated STAT1 interacts with and up-regulates activities of the pro-proliferative transcription factor Krüppel-like factor 5.
Du JX; Yun CC; Bialkowska A; Yang VW
J Biol Chem; 2007 Feb; 282(7):4782-4793. PubMed ID: 17178721
[TBL] [Abstract][Full Text] [Related]
38. TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis.
Zhao D; Zhi X; Zhou Z; Chen C
Carcinogenesis; 2012 Jan; 33(1):59-67. PubMed ID: 22045023
[TBL] [Abstract][Full Text] [Related]
39. KLF5 regulated lncRNA RP1 promotes the growth and metastasis of breast cancer via repressing p27kip1 translation.
Jia X; Shi L; Wang X; Luo L; Ling L; Yin J; Song Y; Zhang Z; Qiu N; Liu H; Deng M; He Z; Li H; Zheng G
Cell Death Dis; 2019 May; 10(5):373. PubMed ID: 31073122
[TBL] [Abstract][Full Text] [Related]
40. UCHL1 contributes to insensitivity to endocrine therapy in triple-negative breast cancer by deubiquitinating and stabilizing KLF5.
Li J; Liang Y; Zhou S; Chen J; Wu C
Breast Cancer Res; 2024 Mar; 26(1):44. PubMed ID: 38468288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
